周?chē)?/c>的原始間充質(zhì)群眾口封閉了小芽。
Mesenchymal stem cells(MSCs) with capacities of multi-differentiation and anti-immune rejection have been widely used in medicine research.
間充質(zhì)干細(xì)胞因具有多向分化潛能及植入體內(nèi)無(wú)排斥反應(yīng)等特性而被廣泛應(yīng)用于醫(yī)學(xué)領(lǐng)域。
Mesenchymal stem cells (MSC) have been identified in a variety of adult tissues as a population of pluripotential self-renewing cells.
間充質(zhì)干細(xì)胞（MSC）已經(jīng)被證實(shí)是一種多潛能自我更新細(xì)胞存在于多種成體組織中。
abstract: BACKGROUND: Mesenchymal stem cells(MSCs) could differentiate into nerve cells, but the molecular mechanism is still unknown.
背景：間充質(zhì)干細(xì)胞可向神經(jīng)方向轉(zhuǎn)化，但分子機(jī)制目前不清楚。
Currently, bone marrow derived mesenchymal stem cells (MSCs) are the best available cell population for tendon tissue engineering.
骨髓源間充質(zhì)干細(xì)胞是肌腱組織工程最為常用的種子細(xì)胞。
Mesenchymal alterations include thickening of the basal lamina, smooth muscle hyperplasia, fibrosis and inflammatory cell accumulation.
間質(zhì)的改變，包括基底層增厚，平滑肌增生，纖維化和炎癥細(xì)胞的積累。
Mesenchymal stem cells are commonly harvested from bone marrow. A few studies are on umbilical cord blood-mesenchymal stem cells (UCB-MSCs).
治療所使用的間充質(zhì)干細(xì)胞基本上都來(lái)源于骨髓，使用臍血間充質(zhì)干細(xì)胞的研究報(bào)道較少。
The ameloblast differentiation is controlled by sequential epithelial-mesenchymal interactions during tooth morphogenesis.
成釉細(xì)胞的分化是由牙齒形態(tài)發(fā)生期上皮和間充質(zhì)的一系列相互作用調(diào)控的。
The immunoregulatory effects of mesenchymal stem cell (MSC) and its application have become a hot research topic in recent years.
間充質(zhì)干細(xì)胞的免疫調(diào)節(jié)作用已成為眾多學(xué)者關(guān)注的熱點(diǎn)。
Multipotent mesenchymal stromal cells (MSC) are currently under intense investigation to determine their role in cellular therapy.
多骨髓基質(zhì)細(xì)胞（MSC）目前正在緊張的調(diào)查，以確定它們的作用，細(xì)胞療法。
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal (GI) tract.
胃腸道基質(zhì)瘤是胃腸道的間質(zhì)瘤中最常見(jiàn)的。
Recently there has been a trend towards the use of mesenchymal stem cells from bone marrow and fat.
最近出現(xiàn)了一種趨勢(shì)，利用來(lái)自骨髓和脂肪間充質(zhì)的干細(xì)胞。
The latter is a process whereby the transplanted tissue induces mesenchymal cells of the recipient to differentiate into osteoblastic cells.
骨誘導(dǎo)活性是指移植組織通過(guò)誘導(dǎo)受體組織的間充質(zhì)細(xì)胞向成骨細(xì)胞分化。
Bone marrow mesenchymal stem cells can be isolated, expanded, and stimulated to differentiate into various tissues in vitro.
骨髓間充質(zhì)干細(xì)胞因其可獲得性、可擴(kuò)增性和可多向分化性，是理想的組織工程種子細(xì)胞，用于構(gòu)建工程組織。
Conclusion The autologous cord blood serum method could effectively culture mesenchymal stem cells with hepatogenic differentiation ability.
結(jié)論采用自體臍血清有效地培養(yǎng)臍帶聞充質(zhì)干細(xì)胞，具備向肝細(xì)胞的分化能力。
some specimen had manifest mesenchymal hyperplasia, most of the hyperplasia cell were adipose cell, the adipose cell obviously augmentation.
部分標(biāo)本間質(zhì)增生明顯，以脂肪細(xì)胞增生為主，脂肪細(xì)胞明顯增大。
Bone marrow stromal cells are the unique mesenchymal stem cells which can differentiated into many non hematopoietic tissues.
骨髓基質(zhì)細(xì)胞是一類(lèi)獨(dú)特的間質(zhì)干細(xì)胞，可分化為多種非造血系的組織。
once the mesenchymal cells have received their initial instructions , they start sending signals back to the epithelial cells.
間質(zhì)細(xì)胞一接收到最初的指令后，就會(huì)開(kāi)始將訊號(hào)回傳給上皮細(xì)胞。
Soft tissue sarcoma (STS) is an extremely heterogeneous group of rare tumors that share a putative mesenchymal cell origin.
軟組織肉瘤（街）是一個(gè)極其罕見(jiàn)的異構(gòu)組腫瘤共用一個(gè)假定的間充質(zhì)細(xì)胞來(lái)源。
Mesenchymal stem cells are immune-modulators, which means that they will not be rejected by the patient's immune system.
間充質(zhì)干細(xì)胞是免疫調(diào)節(jié)劑，意味著它們不會(huì)引起患者的免疫系統(tǒng)排異。
The endothelial cells might participate in the fusion of the outflow tract ridges by endothelial-mesenchymal transformation.
內(nèi)皮細(xì)胞-間充質(zhì)細(xì)胞轉(zhuǎn)化可能參與了流出道嵴融合；
A confident preoperative diagnosis of mesenchymal hamartoma base on these radiological features can be made.
由上述放射殘檢查之獨(dú)特表現(xiàn)，吾人可對(duì)肝間葉性畸胎瘤做一可信度極佳的開(kāi)刀前診斷。
Another type of adult stem cell, the mesenchymal stem cell, has entered the scene as a developing therapy.
另一種類(lèi)型的成人干細(xì)胞，間質(zhì)干細(xì)胞，作為一個(gè)發(fā)展中的治療已經(jīng)進(jìn)入現(xiàn)場(chǎng)。
"We found that the regulation of alternative splicing is different in mesenchymal versus epithelial cells, " Garcia-Blanco said.
我們在對(duì)間充質(zhì)性細(xì)胞與上皮性細(xì)胞的比較中發(fā)現(xiàn)，選擇剪切的規(guī)律是不一樣的。
Researchers found that breast cancer stem cells are regulated by a type of cell derived from bone marrow, called mesenchymal stem cells.
研究人員發(fā)現(xiàn)，間質(zhì)干細(xì)胞（來(lái)源于骨髓）調(diào)控著乳腺癌干細(xì)胞。
Objective To investigate the clinical features, diagnosis and treatment of mesenchymal hamartoma of the liver.
目的分析探討肝間葉性錯(cuò)構(gòu)瘤的臨床特征與診治方法。
We herein made a review on the immunosuppressive effect of mesenchymal stem cell and its mechanism.
本文簡(jiǎn)要綜述間充質(zhì)干細(xì)胞的免疫抑制作用和機(jī)理。
abstract: Objective To investigate the effects of the donor age on isolation and culture of human bone marrow mesenchymal stem cells(MSCs).
目的：探討年齡對(duì)骨髓間充質(zhì)干細(xì)胞分離培養(yǎng)的影響以及在臨床治療中的意義。
OBJECTIVE: To investigate osteogenic characteristics of rat bone marrow mesenchymal stem cells co-cultured with osteoblasts.
目的：在與成骨細(xì)胞共培養(yǎng)的條件下，觀察大鼠骨髓間充質(zhì)干細(xì)胞的成骨特性。
Phyllodes tumor(PT)of breast is a special kind of breast tumor, composed of both epithelial and mesenchymal components.
乳腺分葉狀肉瘤是一種特殊類(lèi)型的乳腺腫瘤，由上皮和間質(zhì)成分構(gòu)成。
Objective: To investigate the isolation, culture and identification of human amniotic epithelial cells and mesenchymal cells.
目的：探討人羊膜上皮細(xì)胞和羊膜間質(zhì)細(xì)胞的分離、培養(yǎng)及鑒定。
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract.
腸胃道基質(zhì)細(xì)胞瘤是腸胃道最常見(jiàn)的間葉細(xì)胞瘤。
ObjectiveDental papilla mesenchymal cells differentiate into primary odontoblasts and form primary dentin during tooth development.
目的在牙齒發(fā)育期間，牙乳頭間充質(zhì)細(xì)胞分化為成牙本質(zhì)細(xì)胞，形成原發(fā)性牙本質(zhì)；
These characteristic radiologic finding led to the diagnosis of hepatic mesenchymal hamartoma.
這些特殊的放射線學(xué)變化幫助我們做肝臟間葉缺陷瘤的正確診斷。
Objective: To isolate and culture mesenchymal stem cells(MSCs) derived from human bone marrow and transfect the cells by lentiviral vectors.
目的：分離培養(yǎng)人骨髓來(lái)源間質(zhì)干細(xì)胞（mesenchymalstemcells，MSCs）并進(jìn)行慢病毒載體介導(dǎo)的基因轉(zhuǎn)染研究。
Cysts occur as a result of mesenchymal degeneration of or from dilated bile ducts and lymphatic.
囊腫的發(fā)生由于間葉組織的變性或膽管及淋巴管的擴(kuò)張。
Objective To test the potential of human marrow mesenchymal stem cells (MSCs) differentiating into cardiovascular tissue.
目的驗(yàn)證人骨髓間充質(zhì)干細(xì)胞（MSC）分化為心血管組織的潛能。
Evaluation of Posterolateral Spinal Fusion Using Mesenchymal Stem Cells: Differences With or Without Osteogenic Differentiation.
評(píng)價(jià)后路腰椎融合術(shù)中使用間充質(zhì)干細(xì)胞：用與不用的成骨分化區(qū)別。
OBJECTIVE: To summarize the repair effect and value of bone mesenchymal stem cells for osteonecrosis of the femoral head.
目的：綜述骨髓間充質(zhì)干細(xì)胞在治療股骨頭壞死的修復(fù)作用及價(jià)值。
英 
